A comparative pharmaceutico analytical and clinical study of Rasnasaptak Kashaya And Rasnapanchak Kashaya Ghanvati in Amavata w.s.r.to Rheumatoid Arthritis
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Subjective Parameter- Grading will be done with sign & symptoms of Amavata
研究概览
简要总结
In this trial we are selecting patients of Amavata in two groups, in which we will do intervention study of study with Rasnasaptak kashaya ghanvati and Rasnapanchak kashaya ghanvati with the dose of two tablets of 500 mg BD assesment will be done on the subjective and objective parameters for the Amavata.
Route of Drug Adminitration - Oral
Follow up- Day 10, day 20, day 30
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Open Label
入排标准
- 年龄范围
- 20.00 Year(s) 至 70.00 Year(s)(—)
- 性别
- All
入选标准
- •Patient willing for trial
- •Either Sex will be selected
- •Newly Diagnosed case and patient not on any medication since one month will be selected
- •Patient having classical symptoms of Rheumatoid Arthritis will be Selected.
排除标准
- •Age more than 70 yrs and less than 20 yrs.
- •Patient not willing for trial.
- •Pregnancy and lactating mothers
- •Patients suffering from any known case of severe systemic disorder like Crohn Disease, SLE, Graves disease, AIDS etc, which may interfere with the course of treatment will be excluded.
结局指标
主要结局
Subjective Parameter- Grading will be done with sign & symptoms of Amavata
时间窗: After one month intervention of Rasnasaptak kashaya Ghanvati and Rasnapanchak kashaya Ghanvati orally.
RA factor,ESR,CRP,SGOT,SGPT,Uric Acid,HB,TLC to rule out other pathologies
时间窗: After one month intervention of Rasnasaptak kashaya Ghanvati and Rasnapanchak kashaya Ghanvati orally.
次要结局
- Subjective parameter-grading will be done with sign & symptoms of Amavata RA factor, ESR,CRP,SGOT,SGPT,Uric acid,HB(After one mmonth intervention of Rasnasaptak Kashaya Ghanvati & Rasnapanchak Kashaya Ghanvati)
